<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.pharmtech.com/view/eu-clears-astrazeneca-s-trixeo-for-asthma-opening-new-manufacturing-demand-for-single-inhaler-triple-therapy</loc><lastmod>2026-09-23T14:11:00Z</lastmod><news:news><news:publication_date>2026-09-23T14:11:00Z</news:publication_date>
        <news:title><![CDATA[EU Clears AstraZeneca's Trixeo for Asthma, Opening New Manufacturing Demand for Single-Inhaler Triple Therapy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/pharma-fundamentals-digital-pathology-in-drug-development-part-1</loc><lastmod>2026-09-23T14:00:00Z</lastmod><news:news><news:publication_date>2026-09-23T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Pharma Fundamentals: Digital Pathology in Drug Development, Part 1]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/sweden-a-powerhouse-for-early-stage-innovation</loc><lastmod>2026-09-23T12:46:00Z</lastmod><news:news><news:publication_date>2026-09-23T12:46:00Z</news:publication_date>
        <news:title><![CDATA[Sweden, a Powerhouse for Early Stage Innovation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/strategic-role-of-innovative-lab-informatics-solution-for-enabling-smarter-r-d-in-pharma</loc><lastmod>2026-09-23T04:08:00Z</lastmod><news:news><news:publication_date>2026-09-23T04:08:00Z</news:publication_date>
        <news:title><![CDATA[Strategic Role of Innovative Lab Informatics Solution for Enabling Smarter R&D in Pharma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/unlocking-efficiency-and-compliance-the-strategic-advantage-of-lims-in-pharmaceutical-manufacturing</loc><lastmod>2026-09-23T04:08:00Z</lastmod><news:news><news:publication_date>2026-09-23T04:08:00Z</news:publication_date>
        <news:title><![CDATA[Unlocking Efficiency and Compliance: The Strategic Advantage of LIMS in Pharmaceutical Manufacturing]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/positioning-your-pharmaceutical-lab-for-success-overcome-your-pharmaceutical-informatics-challenges-with-a-purpose-built-validated-lims</loc><lastmod>2026-09-23T04:08:00Z</lastmod><news:news><news:publication_date>2026-09-23T04:08:00Z</news:publication_date>
        <news:title><![CDATA[Positioning Your Pharmaceutical Lab for Success: Overcome Your Pharmaceutical Informatics Challenges with a Purpose-built Validated LIMS]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/the-fda-finalizes-rule-recognizing-non-animal-testing-methods-building-on-year-long-reduction-push</loc><lastmod>2026-09-22T15:06:00Z</lastmod><news:news><news:publication_date>2026-09-22T15:06:00Z</news:publication_date>
        <news:title><![CDATA[The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/pharmtech-ai-pulse-check-fixing-ai-slop-at-the-source</loc><lastmod>2026-09-22T14:26:15.285Z</lastmod><news:news><news:publication_date>2026-09-22T14:26:15.285Z</news:publication_date>
        <news:title><![CDATA[PharmTech AI Pulse Check: Fixing AI Slop at the Source]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/inluriyo-verzenio-combo-doubles-pfs-adds-oral-oncology-complexity</loc><lastmod>2026-09-21T15:16:57.228Z</lastmod><news:news><news:publication_date>2026-09-21T15:16:57.228Z</news:publication_date>
        <news:title><![CDATA[Inluriyo-Verzenio Combo Doubles PFS, Adds Oral Complexity]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/cphi-milan-brings-back-leadership-summit-as-supply-chain-and-manufacturing-pressures-ramp-up</loc><lastmod>2026-09-21T13:57:00Z</lastmod><news:news><news:publication_date>2026-09-21T13:57:00Z</news:publication_date>
        <news:title><![CDATA[CPHI Milan Brings Back Leadership Summit as Supply Chain and Manufacturing Pressures Ramp Up]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/pharmtech-weekly-roundup-september-18-2026</loc><lastmod>2026-09-18T16:57:00Z</lastmod><news:news><news:publication_date>2026-09-18T16:57:00Z</news:publication_date>
        <news:title><![CDATA[PharmTech Weekly Roundup—September 18, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/q-a-how-can-sponsors-respond-to-clinical-trial-customs-delays-</loc><lastmod>2026-09-18T14:12:25.053Z</lastmod><news:news><news:publication_date>2026-09-18T14:12:25.053Z</news:publication_date>
        <news:title><![CDATA[Q&A: How Can Sponsors Respond to Clinical Trial Customs Delays?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/introducing-the-pharmtech-ai-pulse-check-expert-video-series</loc><lastmod>2026-09-18T13:49:08.557Z</lastmod><news:news><news:publication_date>2026-09-18T13:49:08.557Z</news:publication_date>
        <news:title><![CDATA[Introducing the "PharmTech AI Pulse Check" Expert Video Series]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/ai-agents-satisfy-cgmp-documentation-requirements</loc><lastmod>2026-09-18T11:00:00Z</lastmod><news:news><news:publication_date>2026-09-18T11:00:00Z</news:publication_date>
        <news:title><![CDATA[Can AI Agents Satisfy CGMP Documentation Requirements?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/cphi-milan-2026-trends-in-pharma</loc><lastmod>2026-09-17T17:12:00Z</lastmod><news:news><news:publication_date>2026-09-17T17:12:00Z</news:publication_date>
        <news:title><![CDATA[CPHI Milan 2026: Trends in Pharma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/cphi-milan-2026-ai-and-bioavailability-part-2</loc><lastmod>2026-09-17T14:50:00Z</lastmod><news:news><news:publication_date>2026-09-17T14:50:00Z</news:publication_date>
        <news:title><![CDATA[CPHI Milan 2026: AI and Bioavailability, Part 2]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/creating-value-through-early-phase-trial-design-how-the-fda-s-single-phase-3-pivot-impacts-early-phases</loc><lastmod>2026-09-17T14:01:05.136Z</lastmod><news:news><news:publication_date>2026-09-17T14:01:05.136Z</news:publication_date>
        <news:title><![CDATA[Creating Value Through Early Phase Trial Design: How the FDA’s Single Phase 3 Pivot Impacts Early Phases]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/two-audit-case-studies-reveal-the-cost-of-incomplete-corrective-actions</loc><lastmod>2026-09-16T19:16:57.029Z</lastmod><news:news><news:publication_date>2026-09-16T19:16:57.029Z</news:publication_date>
        <news:title><![CDATA[Two Audit Case Studies Reveal the Cost of Incomplete Corrective Actions]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/new-spray-drying-capacity-signals-faster-paths-for-poorly-soluble-drugs</loc><lastmod>2026-09-16T15:58:25.090Z</lastmod><news:news><news:publication_date>2026-09-16T15:58:25.090Z</news:publication_date>
        <news:title><![CDATA[Spray Drying Capacity Signals Faster Paths for Poorly Soluble Drugs]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/raw-material-complexities-and-strategies-with-for-advanced-therapies</loc><lastmod>2026-09-16T15:27:00Z</lastmod><news:news><news:publication_date>2026-09-16T15:27:00Z</news:publication_date>
        <news:title><![CDATA[Raw Material Complexities and Strategies with for Advanced Therapies]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/fda-s-ind-pilot-puts-cmc-review-first</loc><lastmod>2026-09-16T11:51:09.233Z</lastmod><news:news><news:publication_date>2026-09-16T11:51:09.233Z</news:publication_date>
        <news:title><![CDATA[FDA's IND Pilot Puts CMC Review First]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/intravenous-to-subcutaneous-biologics</loc><lastmod>2026-09-15T21:00:44.875Z</lastmod><news:news><news:publication_date>2026-09-15T21:00:44.875Z</news:publication_date>
        <news:title><![CDATA[The Shift From Intravenous to Subcutaneous Biologics in 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/lessons-for-ai-governance-in-quality-systems</loc><lastmod>2026-09-15T19:22:01.493Z</lastmod><news:news><news:publication_date>2026-09-15T19:22:01.493Z</news:publication_date>
        <news:title><![CDATA[Lessons For AI Governance in Quality Systems]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/successful-internal-audit-planning-and-execution</loc><lastmod>2026-09-15T18:32:00Z</lastmod><news:news><news:publication_date>2026-09-15T18:32:00Z</news:publication_date>
        <news:title><![CDATA[Successful Internal Audit Planning and Execution]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/driving-quality-culture-to-manage-risk-lessons-from-an-fda-inspection-response</loc><lastmod>2026-09-15T15:59:57.986Z</lastmod><news:news><news:publication_date>2026-09-15T15:59:57.986Z</news:publication_date>
        <news:title><![CDATA[Driving Quality Culture to Manage Risk: Lessons from an FDA Inspection Response]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/the-risk-file-was-never-meant-to-be-a-once-a-year-exercise</loc><lastmod>2026-09-15T13:46:42.747Z</lastmod><news:news><news:publication_date>2026-09-15T13:46:42.747Z</news:publication_date>
        <news:title><![CDATA[The Risk File Was Never Meant to Be a Once-a-Year Exercise]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/what-is-your-vision-quotient</loc><lastmod>2026-09-15T04:17:00Z</lastmod><news:news><news:publication_date>2026-09-15T04:17:00Z</news:publication_date>
        <news:title><![CDATA[What is YOUR Vision Quotient?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/how-industrywide-consolidation-affects-the-future-of-packaging</loc><lastmod>2026-09-15T04:17:00Z</lastmod><news:news><news:publication_date>2026-09-15T04:17:00Z</news:publication_date>
        <news:title><![CDATA[How Industrywide Consolidation Affects the Future of Packaging]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/mature-medicines-divestment-signals-shift-in-manufacturing-strategy</loc><lastmod>2026-09-14T18:42:23.754Z</lastmod><news:news><news:publication_date>2026-09-14T18:42:23.754Z</news:publication_date>
        <news:title><![CDATA[Mature Medicines Divestment Signals Shift in Manufacturing Strategy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/cphi-milan-2026-ai-and-bioavailability-part-1</loc><lastmod>2026-09-14T18:19:00Z</lastmod><news:news><news:publication_date>2026-09-14T18:19:00Z</news:publication_date>
        <news:title><![CDATA[CPHI Milan 2026: AI and Bioavailability, Part 1]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/high-concentration-low-volume-subcutaneous-formulation</loc><lastmod>2026-09-14T04:53:00Z</lastmod><news:news><news:publication_date>2026-09-14T04:53:00Z</news:publication_date>
        <news:title><![CDATA[High-Concentration, Low-Volume Subcutaneous Formulation]]></news:title>
        <news:keywords><![CDATA[webcasts]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/accelerating-innovation-with-stick-packs-from-development-to-patient</loc><lastmod>2026-09-14T04:53:00Z</lastmod><news:news><news:publication_date>2026-09-14T04:53:00Z</news:publication_date>
        <news:title><![CDATA[Accelerating Innovation with Stick Packs From Development to Patient]]></news:title>
        <news:keywords><![CDATA[webcasts]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/pharmtech-weekly-roundup-september-11-2026</loc><lastmod>2026-09-11T15:34:00Z</lastmod><news:news><news:publication_date>2026-09-11T15:34:00Z</news:publication_date>
        <news:title><![CDATA[PharmTech Weekly Roundup—September 11, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/six-month-ecoa-timelines-signal-need-for-earlier-planning</loc><lastmod>2026-09-11T11:30:00Z</lastmod><news:news><news:publication_date>2026-09-11T11:30:00Z</news:publication_date>
        <news:title><![CDATA[Six-Month eCOA Timelines Signal Need for Earlier Planning]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/assessment-of-silicone-oil-cleaning-on-indirect-surfaces-in-aseptic-manufacturing</loc><lastmod>2026-09-10T20:19:14.553Z</lastmod><news:news><news:publication_date>2026-09-10T20:19:14.553Z</news:publication_date>
        <news:title><![CDATA[Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/shilpa-cdmo-to-launch-as-dedicated-complex-small-molecule-contract-development-and-manufacturing-brand-at-cphi-milan</loc><lastmod>2026-09-10T17:37:00Z</lastmod><news:news><news:publication_date>2026-09-10T17:37:00Z</news:publication_date>
        <news:title><![CDATA[Shilpa CDMO to Launch as Dedicated Complex Small-Molecule Contract Development and Manufacturing Brand at CPHI Milan]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/european-regulators-prepare-the-pharma-industry-for-future-changes-as-legislation-is-formalized</loc><lastmod>2026-09-10T14:31:00Z</lastmod><news:news><news:publication_date>2026-09-10T14:31:00Z</news:publication_date>
        <news:title><![CDATA[European Regulators Prepare the Pharma Industry for Future Changes as Legislation Is Formalized]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/data-aggregation-drives-ai-s-impact-on-clinical-supply-chains</loc><lastmod>2026-09-10T11:30:00Z</lastmod><news:news><news:publication_date>2026-09-10T11:30:00Z</news:publication_date>
        <news:title><![CDATA[Data Aggregation Drives AI's Impact on Clinical Supply Chains]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/ima-group-to-showcase-all-in-one-solutions-at-cphi-milan</loc><lastmod>2026-09-09T15:59:00Z</lastmod><news:news><news:publication_date>2026-09-09T15:59:00Z</news:publication_date>
        <news:title><![CDATA[IMA Group to Showcase All-in-One Solutions at CPHI Milan]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/why-oral-solid-dosage-validation-is-a-business-continuity-function-not-just-a-compliance-requirement</loc><lastmod>2026-09-09T14:26:15.455Z</lastmod><news:news><news:publication_date>2026-09-09T14:26:15.455Z</news:publication_date>
        <news:title><![CDATA[Why Oral Solid Dosage Validation Is a Business Continuity Function, Not Just a Compliance Requirement]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/technology-transfer-success-drivers-and-obstacles-explained</loc><lastmod>2026-09-09T12:59:00Z</lastmod><news:news><news:publication_date>2026-09-09T12:59:00Z</news:publication_date>
        <news:title><![CDATA[Technology Transfer: Success Drivers and Obstacles Explained ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/how-to-vet-importer-of-record-partners-for-clinical-trials</loc><lastmod>2026-09-09T11:30:00Z</lastmod><news:news><news:publication_date>2026-09-09T11:30:00Z</news:publication_date>
        <news:title><![CDATA[How to Vet Importer of Record Partners for Clinical Trials]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/putting-sustainability-to-work-in-pharma</loc><lastmod>2026-09-08T15:14:00Z</lastmod><news:news><news:publication_date>2026-09-08T15:14:00Z</news:publication_date>
        <news:title><![CDATA[Putting Sustainability to Work in Pharma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/aaps-pharmsci-360-cmc-strategies-part-2</loc><lastmod>2026-09-08T12:32:24.953Z</lastmod><news:news><news:publication_date>2026-09-08T12:32:24.953Z</news:publication_date>
        <news:title><![CDATA[AAPS PharmSci 360: CMC Strategies, Part 2]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/managing-global-trial-supply-risk-expert-insights</loc><lastmod>2026-09-08T11:30:00Z</lastmod><news:news><news:publication_date>2026-09-08T11:30:00Z</news:publication_date>
        <news:title><![CDATA[Managing Global Trial Supply Risk: Expert Insights]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/accelerating-and-streamlining-microbial-process-development-with-a-novel-technology-sept-2026-</loc><lastmod>2026-09-08T04:00:00Z</lastmod><news:news><news:publication_date>2026-09-08T04:00:00Z</news:publication_date>
        <news:title><![CDATA[Accelerating and Streamlining Microbial Process Development with a Novel Technology (Sept 2026)]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/shaping-the-future-of-microbial-development-from-gene-to-gmp-sept-2026</loc><lastmod>2026-09-08T04:00:00Z</lastmod><news:news><news:publication_date>2026-09-08T04:00:00Z</news:publication_date>
        <news:title><![CDATA[Shaping the Future of Microbial Development: From Gene to GMP (Sept 2026)]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/simplifying-downstream-processing-for-complex-biologics-sept-2026-</loc><lastmod>2026-09-08T04:00:00Z</lastmod><news:news><news:publication_date>2026-09-08T04:00:00Z</news:publication_date>
        <news:title><![CDATA[Simplifying Downstream Processing for Complex Biologics (Sept 2026)]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/pharmtech-weekly-roundup-september-4-2026</loc><lastmod>2026-09-04T17:17:00Z</lastmod><news:news><news:publication_date>2026-09-04T17:17:00Z</news:publication_date>
        <news:title><![CDATA[PharmTech Weekly Roundup—September 4, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/what-an-alexander-disease-approval-means-for-rna-developers</loc><lastmod>2026-09-04T14:59:53.301Z</lastmod><news:news><news:publication_date>2026-09-04T14:59:53.301Z</news:publication_date>
        <news:title><![CDATA[What an Alexander Disease Approval Means for RNA Developers]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/an-introduction-to-cphi-milan-2026</loc><lastmod>2026-09-03T15:51:56.565Z</lastmod><news:news><news:publication_date>2026-09-03T15:51:56.565Z</news:publication_date>
        <news:title><![CDATA[An Introduction to CPHI Milan 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/application-of-predictive-modeling-in-the-development-of-amorphous-solid-dispersions</loc><lastmod>2026-09-03T12:31:00Z</lastmod><news:news><news:publication_date>2026-09-03T12:31:00Z</news:publication_date>
        <news:title><![CDATA[Application of Predictive Modeling in the Development of Amorphous Solid Dispersions ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/car-t-cell-trial-pause-signals-new-manufacturing-risk-review</loc><lastmod>2026-09-02T18:57:13.016Z</lastmod><news:news><news:publication_date>2026-09-02T18:57:13.016Z</news:publication_date>
        <news:title><![CDATA[CAR T-Cell Trial Pause Signals New Manufacturing Risk Review]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/aaps-pharmsci-360-cmc-strategies-part-1</loc><lastmod>2026-09-02T15:31:22.637Z</lastmod><news:news><news:publication_date>2026-09-02T15:31:22.637Z</news:publication_date>
        <news:title><![CDATA[AAPS PharmSci 360: CMC Strategies, Part 1]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/novartis-3-billion-enzyme-licensing-deal-means-for-formulation</loc><lastmod>2026-09-02T14:51:55.016Z</lastmod><news:news><news:publication_date>2026-09-02T14:51:55.016Z</news:publication_date>
        <news:title><![CDATA[What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/aaps-pharmsci-360-microstructure-intelligence-in-predictive-drug-development-part-2</loc><lastmod>2026-09-02T12:19:45.375Z</lastmod><news:news><news:publication_date>2026-09-02T12:19:45.375Z</news:publication_date>
        <news:title><![CDATA[AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 2]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/from-phase-1-screening-to-commercial-strategy-selecting-the-right-amorphous-solid-dispersion-technology-early</loc><lastmod>2026-09-02T04:13:00Z</lastmod><news:news><news:publication_date>2026-09-02T04:13:00Z</news:publication_date>
        <news:title><![CDATA[From Phase 1 Screening to Commercial Strategy: Selecting the Right Amorphous Solid Dispersion Technology Early]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/cphi-milan-names-2026-pharma-awards-finalists</loc><lastmod>2026-09-01T14:46:00Z</lastmod><news:news><news:publication_date>2026-09-01T14:46:00Z</news:publication_date>
        <news:title><![CDATA[CPHI Milan Names 2026 Pharma Awards Finalists]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/aaps-pharmsci-360-microstructure-intelligence-in-predictive-drug-development-part-1</loc><lastmod>2026-09-01T14:07:43.940Z</lastmod><news:news><news:publication_date>2026-09-01T14:07:43.940Z</news:publication_date>
        <news:title><![CDATA[AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 1]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/regulatory-roundup-august-2026</loc><lastmod>2026-08-31T18:08:00Z</lastmod><news:news><news:publication_date>2026-08-31T18:08:00Z</news:publication_date>
        <news:title><![CDATA[Regulatory Roundup—August 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/from-detection-to-prediction-analytical-approaches-for-nitrosamine-risk</loc><lastmod>2026-08-31T15:25:00Z</lastmod><news:news><news:publication_date>2026-08-31T15:25:00Z</news:publication_date>
        <news:title><![CDATA[From Detection to Prediction: Analytical Approaches for Nitrosamine Risk]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/lilly-merida-deal-has-implications-for-autoantibody-diseases</loc><lastmod>2026-08-31T14:40:00Z</lastmod><news:news><news:publication_date>2026-08-31T14:40:00Z</news:publication_date>
        <news:title><![CDATA[Lilly's $2.875B Merida Deal Has Implications for Autoantibody Diseases]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/what-to-know-from-fdas-end-of-august-activity</loc><lastmod>2026-08-28T15:29:19.689Z</lastmod><news:news><news:publication_date>2026-08-28T15:29:19.689Z</news:publication_date>
        <news:title><![CDATA[What to Know from the FDA’s End of August Activity]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/pharmtech-weekly-roundup-august-28-2026</loc><lastmod>2026-08-28T14:21:25.797Z</lastmod><news:news><news:publication_date>2026-08-28T14:21:25.797Z</news:publication_date>
        <news:title><![CDATA[PharmTech Weekly Roundup—August 28, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/pharma-fundamentals-risks-and-regulations-for-hold-times-in-biopharmaceuticals</loc><lastmod>2026-08-27T13:05:00Z</lastmod><news:news><news:publication_date>2026-08-27T13:05:00Z</news:publication_date>
        <news:title><![CDATA[Pharma Fundamentals: Risks and Regulations for Hold Times in Biopharmaceuticals]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/pharma-fundamentals-hold-times-in-biopharmaceuticals-risks-and-regulations</loc><lastmod>2026-08-27T13:00:00Z</lastmod><news:news><news:publication_date>2026-08-27T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Pharma Fundamentals: Hold Times in Biopharmaceuticals, Risks and Regulations]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/formulating-for-function-strategies-to-maximize-stability-of-emerging-biologics</loc><lastmod>2026-08-27T12:32:00Z</lastmod><news:news><news:publication_date>2026-08-27T12:32:00Z</news:publication_date>
        <news:title><![CDATA[Strategies to Maximize Stability of Emerging Biologics]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/pharmas-next-ai-problem-is-authority</loc><lastmod>2026-08-27T11:52:46.543Z</lastmod><news:news><news:publication_date>2026-08-27T11:52:46.543Z</news:publication_date>
        <news:title><![CDATA[Pharma's Next AI Problem Is Authority]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/rasonque-s-60-survival-benefit-what-it-means-for-oncology-pipelines</loc><lastmod>2026-08-26T19:10:51.448Z</lastmod><news:news><news:publication_date>2026-08-26T19:10:51.448Z</news:publication_date>
        <news:title><![CDATA[Rasonque's 60% Survival Benefit: What It Means for Oncology Pipelines]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/predictive-modelling-fix-fragmented-pharma-development-data</loc><lastmod>2026-08-26T15:01:34.301Z</lastmod><news:news><news:publication_date>2026-08-26T15:01:34.301Z</news:publication_date>
        <news:title><![CDATA[Can Predictive Modelling Fix Fragmented Pharma Development Data?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/rethinking-the-path-from-spray-dried-dispersions-to-tablets-the-role-of-continuous-direct-compression</loc><lastmod>2026-08-26T14:00:00Z</lastmod><news:news><news:publication_date>2026-08-26T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Rethinking the Path from Spray-Dried Dispersions to Tablets: The Role of Continuous Direct Compression]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/3d-printing-revolutionizing-tissue-engineering-and-regenerative-medicine-in-europe</loc><lastmod>2026-08-26T10:50:01.116Z</lastmod><news:news><news:publication_date>2026-08-26T10:50:01.116Z</news:publication_date>
        <news:title><![CDATA[3D Printing Is Revolutionizing Tissue Engineering and Regenerative Medicine in Europe ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/gsks-jemperli-rectal-cancer-filing-signals-biologics-capacity-shift</loc><lastmod>2026-08-25T19:00:00Z</lastmod><news:news><news:publication_date>2026-08-25T19:00:00Z</news:publication_date>
        <news:title><![CDATA[GSK's Jemperli Rectal Cancer Filing Signals Biologics Capacity Shift]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/what-the-mckesson-precision-medicine-deal-signals-for-trial-sponsors</loc><lastmod>2026-08-25T14:50:48.265Z</lastmod><news:news><news:publication_date>2026-08-25T14:50:48.265Z</news:publication_date>
        <news:title><![CDATA[What the McKesson-Precision Medicine Deal Signals for Trial Sponsors]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/must-knows-from-the-rgx-121-hold</loc><lastmod>2026-08-24T18:33:49.250Z</lastmod><news:news><news:publication_date>2026-08-24T18:33:49.250Z</news:publication_date>
        <news:title><![CDATA[Must-Knows from the RGX-121 Hold]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/from-detection-to-prediction-modern-analytical-approaches-for-nitrosamine-risk</loc><lastmod>2026-08-24T17:46:00Z</lastmod><news:news><news:publication_date>2026-08-24T17:46:00Z</news:publication_date>
        <news:title><![CDATA[From Detection to Prediction: Modern Analytical Approaches for Nitrosamine Risk]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/gsdia-gene-therapy-approval-signals-new-path-for-rare-disease-manufacturing</loc><lastmod>2026-08-20T18:06:39.493Z</lastmod><news:news><news:publication_date>2026-08-20T18:06:39.493Z</news:publication_date>
        <news:title><![CDATA[GSDIa Gene Therapy Approval Signals New Path for Rare Disease Manufacturing]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/how-the-nitrosamine-guidance-shift-is-changing-lc-ms-workflows-for-apis-and-peptides</loc><lastmod>2026-08-20T16:40:09.872Z</lastmod><news:news><news:publication_date>2026-08-20T16:40:09.872Z</news:publication_date>
        <news:title><![CDATA[How the Nitrosamine Guidance Shift is Changing LC-MS Workflows for APIs and Peptides]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/how-a-63-patient-trial-delivered-a-fda-approval</loc><lastmod>2026-08-20T15:19:03.878Z</lastmod><news:news><news:publication_date>2026-08-20T15:19:03.878Z</news:publication_date>
        <news:title><![CDATA[How a 63-Patient Trial Delivered an FDA Approval]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/ask-the-expert-complying-with-standards</loc><lastmod>2026-08-20T12:00:00Z</lastmod><news:news><news:publication_date>2026-08-20T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Ask the Expert: Complying with Standards]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/what-does-overtons-fda-nomination-mean-for-drug-reviews-</loc><lastmod>2026-08-19T19:32:43.416Z</lastmod><news:news><news:publication_date>2026-08-19T19:32:43.416Z</news:publication_date>
        <news:title><![CDATA[What Does Overton's FDA Nomination Mean for Drug Reviews?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/ecopipams-d1-receptor-approach-signals-pediatric-neuroscience-pathway</loc><lastmod>2026-08-19T15:24:22.102Z</lastmod><news:news><news:publication_date>2026-08-19T15:24:22.102Z</news:publication_date>
        <news:title><![CDATA[Ecopipam's D1 Receptor Approach Signals New Pediatric Neuroscience Pathway]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/how-ai-can-assist-with-post-marketing-changes</loc><lastmod>2026-08-19T12:33:00Z</lastmod><news:news><news:publication_date>2026-08-19T12:33:00Z</news:publication_date>
        <news:title><![CDATA[How AI Can Assist With Postmarketing Changes]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/qa-why-sponsors-are-turning-to-mixed-fsp-fso-models</loc><lastmod>2026-08-19T11:00:00Z</lastmod><news:news><news:publication_date>2026-08-19T11:00:00Z</news:publication_date>
        <news:title><![CDATA[Q&A: Why Sponsors Are Turning to Mixed FSP/FSO Models]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/the-role-of-continuous-monitoring-systems-in-meeting-regulatory-requirements</loc><lastmod>2026-08-19T04:56:00Z</lastmod><news:news><news:publication_date>2026-08-19T04:56:00Z</news:publication_date>
        <news:title><![CDATA[The Role of Continuous Monitoring Systems in Meeting Regulatory Requirements]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/your-checklist-for-finding-the-right-environmental-monitoring-system</loc><lastmod>2026-08-19T04:56:00Z</lastmod><news:news><news:publication_date>2026-08-19T04:56:00Z</news:publication_date>
        <news:title><![CDATA[Your Checklist for Finding the Right Environmental Monitoring System]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/temperature-and-humidity-monitoring-how-to-maintain-biopharmaceutical-quality-assurance</loc><lastmod>2026-08-19T04:56:00Z</lastmod><news:news><news:publication_date>2026-08-19T04:56:00Z</news:publication_date>
        <news:title><![CDATA[Temperature and Humidity Monitoring: How to Maintain Biopharmaceutical Quality Assurance]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/ensuring-sample-integrity-from-discovery-to-post-market-surveillance</loc><lastmod>2026-08-19T04:56:00Z</lastmod><news:news><news:publication_date>2026-08-19T04:56:00Z</news:publication_date>
        <news:title><![CDATA[Ensuring Sample Integrity from Discovery to Post-Market Surveillance]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/common-sense-continuous-simplifying-integrated-gmp-operations</loc><lastmod>2026-08-19T04:53:00Z</lastmod><news:news><news:publication_date>2026-08-19T04:53:00Z</news:publication_date>
        <news:title><![CDATA[Common Sense Continuous: Simplifying Integrated GMP Operations]]></news:title>
        <news:keywords><![CDATA[webcasts]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/andelyn-biosciences-partners-with-queen-s-university-on-gm2-gangliosidosis-gene-therapy</loc><lastmod>2026-08-18T19:56:00Z</lastmod><news:news><news:publication_date>2026-08-18T19:56:00Z</news:publication_date>
        <news:title><![CDATA[Andelyn Biosciences Partners with Queen's University on GM2 Gangliosidosis Gene Therapy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/dersimelagon-acquisition-highlights-shift-toward-late-stage-rare-disease-licensing</loc><lastmod>2026-08-18T15:12:30.999Z</lastmod><news:news><news:publication_date>2026-08-18T15:12:30.999Z</news:publication_date>
        <news:title><![CDATA[Dersimelagon Acquisition Highlights Shift Toward Late-Stage Rare Disease Licensing]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/chinas-rise-signals-risks-for-us-manufacturers</loc><lastmod>2026-08-18T12:36:42.240Z</lastmod><news:news><news:publication_date>2026-08-18T12:36:42.240Z</news:publication_date>
        <news:title><![CDATA[PharmTech Explained: China's Biotech Rise Signals New Risks for US Manufacturers]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/a-capsule-in-capsule-platform-for-multi-phase-release-of-liquid-and-solid-formulations</loc><lastmod>2026-08-17T14:44:29.748Z</lastmod><news:news><news:publication_date>2026-08-17T14:44:29.748Z</news:publication_date>
        <news:title><![CDATA[A Capsule-in-Capsule Platform for Multiphase Release of Liquid and Solid Formulations]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/q-a-sterile-injectable-manufacturers-gain-new-cdmo-option-as-halo-expands</loc><lastmod>2026-08-17T11:00:00Z</lastmod><news:news><news:publication_date>2026-08-17T11:00:00Z</news:publication_date>
        <news:title><![CDATA[Q&A: Sterile Injectable Manufacturers Gain New CDMO Option as Halo Expands]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/cphi-milan-puts-sustainability-to-work-part-2</loc><lastmod>2026-08-14T19:01:00Z</lastmod><news:news><news:publication_date>2026-08-14T19:01:00Z</news:publication_date>
        <news:title><![CDATA[CPHI Milan Puts Sustainability to Work, Part 2]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/pharmtech-weekly-roundup-august-14-2026</loc><lastmod>2026-08-14T16:34:00Z</lastmod><news:news><news:publication_date>2026-08-14T16:34:00Z</news:publication_date>
        <news:title><![CDATA[PharmTech Weekly Roundup—August 14, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/what-does-tauklarify-approval-mean-for-alzheimer-drug-developers</loc><lastmod>2026-08-14T13:23:30.946Z</lastmod><news:news><news:publication_date>2026-08-14T13:23:30.946Z</news:publication_date>
        <news:title><![CDATA[What Does TAUKLARIFY's Approval Mean for Alzheimer's Drug Developers?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/q-a-why-is-halo-pharma-expanding-into-sterile-injectables-now</loc><lastmod>2026-08-14T11:00:00Z</lastmod><news:news><news:publication_date>2026-08-14T11:00:00Z</news:publication_date>
        <news:title><![CDATA[Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/europe-tried-to-ban-generative-ai-from-critical-gmp-the-ban-may-not-survive-it-does-not-matter-</loc><lastmod>2026-08-13T19:22:00Z</lastmod><news:news><news:publication_date>2026-08-13T19:22:00Z</news:publication_date>
        <news:title><![CDATA[Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/cphi-milan-puts-sustainability-to-work-part-1</loc><lastmod>2026-08-13T16:03:34.942Z</lastmod><news:news><news:publication_date>2026-08-13T16:03:34.942Z</news:publication_date>
        <news:title><![CDATA[CPHI Milan Puts Sustainability to Work, Part 1]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url></urlset>